Pharmaceutical formulation based on a steroidal or non- steroidal anti-inflammatory agent and an antibiotic belonging to the DNA Girase inhibitors group for topical ophthalmic use

摘要

Pharmaceutical formulation based on a steroidal or non- steroidal anti-inflammatory agent and an antibiotic belonging to the DNA Girase inhibitors group for topical ophthalmic use. It comprises: 0.001-5.0% of a steroidal or non-steroidal anti-inflammatory agent or an isomer, or an ester, or one of the pharmaceutically acceptable salts thereof 0.05-5.0% of a DNA Girase inhibitor, or an isomer, or an ester or one of the pharmaceutically acceptable salts thereof and optionally, one or more ingredients selected from isotonizing agents, pH buffers, viscosifiers, wetting agents, chelating agents, antioxidants and/or preservatives, in addition to one or more excipients appropriate for the form of pharmaceutical presentation of the formulation. Said formulation has a pH between 4 and 9. Application in the treatment of ocular inflammatory processes accompanied by infection.